CAH vs COSM
Cardinal Health Inc. and Cosmos Health Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CAH | COSM |
|---|---|---|
| Revenue | $254.2B | $65.3M |
| Net income | $1.7B | $-19.1M |
| Gross margin | 3.8% | 12.1% |
| Net margin | 0.7% | −29.3% |
| Return on equity | — | −89.1% |
| Diluted EPS | $7.23 | −$0.63 |
| Dividend / share | $2.04 | — |
| Payout ratio | 28.6% | — |
| Free cash flow | $4.5B | $-8.5M |
| Equity | $-2.9B | $18.4M |
| Net debt / equity | — | 0.17× |
| Current ratio | 0.88× | 1.00× |
| Revenue CAGR 5y | 9.4% | 3.3% |
| Profit CAGR 5y | 22.9% | — |
CAH bills 3895.2× the revenue of COSM, and COSM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CAH | COSM |
|---|---|---|
| FY2025 | $254.2B | $65.3M |
| FY2024 | $222.6B | $54.4M |
| FY2023 | $226.8B | $53.4M |
| FY2022 | $205.0B | $50.3M |
| FY2021 | $181.3B | $56.2M |
| FY2020 | $162.5B | $55.4M |
| FY2019 | $152.9B | $39.7M |
| FY2018 | $145.5B | $37.1M |
| FY2017 | $136.8B | $30.0M |
| FY2016 | $130.0B | $6.8M |
Net income by year
Bottom line
| Fiscal year | CAH | COSM |
|---|---|---|
| FY2025 | $1.7B | $-19.1M |
| FY2024 | $1.6B | $-16.2M |
| FY2023 | $852.0M | $-18.5M |
| FY2022 | $330.0M | $-13.8M |
| FY2021 | $-938.0M | $-8.0M |
| FY2020 | $611.0M | $820,786 |
| FY2019 | $-3.7B | $-3.3M |
| FY2018 | $1.4B | $-9.1M |
| FY2017 | $256.0M | $-6.2M |
| FY2016 | $1.3B | $-601,002 |